@prefix dc: <http://purl.org/dc/terms/> .
@prefix this: <http://www.tkuhn.ch/bel2nanopub/RAuCMMY_MSTmESKsD26JaAlVNq552YMbgD6CKaquD-PpI> .
@prefix sub: <http://www.tkuhn.ch/bel2nanopub/RAuCMMY_MSTmESKsD26JaAlVNq552YMbgD6CKaquD-PpI#> .
@prefix beldoc: <http://resource.belframework.org/belframework/20131211/knowledge/small_corpus.bel> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix dce: <http://purl.org/dc/elements/1.1/> .
@prefix pav: <http://purl.org/pav/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix belv: <http://www.selventa.com/vocabulary/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix chebi: <http://www.ebi.ac.uk/chebi/searchId.do?chebiId=> .
@prefix obo: <http://purl.obolibrary.org/obo/> .
@prefix Protein: <http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_36080> .
@prefix mgi: <http://www.informatics.jax.org/marker/MGI:> .
@prefix geneProductOf: <http://purl.obolibrary.org/obo/RO_0002204> .
@prefix hasPart: <http://purl.obolibrary.org/obo/BFO_0000051> .
@prefix schem: <http://resource.belframework.org/belframework/20131211/namespace/selventa-legacy-chemicals/> .
@prefix mesh: <http://purl.bioontology.org/ontology/MSH/> .
@prefix occursIn: <http://purl.obolibrary.org/obo/BFO_0000066> .
@prefix hasAnnotation: <http://semanticscience.org/resource/SIO_000255> .
@prefix species: <http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix orcid: <http://orcid.org/> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo;
    a np:Nanopublication .
}

sub:assertion {
  sub:_1 hasPart: schem:Lipopolysaccharide, sub:_2 .
  
  sub:_2 geneProductOf: mgi:107656;
    a Protein: .
  
  sub:_3 rdf:object mesh:D002199;
    rdf:predicate belv:increases;
    rdf:subject sub:_1;
    a rdf:Statement .
  
  sub:_4 occursIn: obo:UBERON_0001986, species:10090;
    hasAnnotation: sub:_5;
    rdf:object sub:_3;
    rdf:predicate belv:decreases;
    rdf:subject chebi:2781;
    a rdf:Statement .
  
  sub:_5 dc:subject "TextLocation";
    rdf:value "Results" .
  
  sub:assertion rdfs:label "a(CHEBI:apocynin) -| (composite(p(MGI:Ifng),a(SCHEM:Lipopolysaccharide)) -> bp(MESHPP:\"Capillary Permeability\"))",
      "composite(p(MGI:Ifng),a(SCHEM:Lipopolysaccharide)) -> bp(MESHPP:\"Capillary Permeability\")" .
}

sub:provenance {
  beldoc: dce:description "Approximately 2000 hand curated statements drawn from 57 PubMeds.";
    dce:rights "Copyright (c) 2011-2012, Selventa. All Rights Reserved.";
    dce:title "BEL Framework Small Corpus Document";
    dc:license "Creative Commons Attribution-Non-Commercial-ShareAlike 3.0 Unported License";
    pav:authoredBy sub:_7;
    pav:version "20131211" .
  
  sub:_6 prov:value """The increased endothelial permeability induced by LPS + IFNγ was attenuated by the
NADPH oxidase inhibitor apocynin (250 µM; based on Coyle and Kader, 2007), iNOS
inhibitor 1400W (50 µM; based on Hortelano et al., 2000), and tripterine (50 nM
and 200 nM; based on Allison et al., 2001) (Figure 1B). Neither apocynin, 1400W
nor tripterine (50 nM and 200 nM) altered the endothelial permeability in the
absence of a pro-inflammatory stimulus (Figure 1B).""";
    prov:wasQuotedFrom pubmed:19508391 .
  
  sub:_7 rdfs:comment "support@belframework.org";
    rdfs:label "Selventa" .
  
  sub:assertion prov:hadPrimarySource pubmed:19508391;
    prov:wasDerivedFrom beldoc:, sub:_6 .
}

sub:pubinfo {
  this: dc:created "2014-07-03T14:31:16.492+02:00"^^xsd:dateTime;
    pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 .
}